Feedback / Questions
Cantrixil (TRX-E-002-1) - Vivesto
https://www.vivesto.com/en/vivesto-reports-positive-preclinical-data-supporting-continued-development-of-cantrixil/#:~:text=Solna%2C%20Sweden%2C%20December%2019%2C,indications%20bladder%20and%20blood%20cancer.
Dec 19, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next